Olema Pharmaceuticals, Inc. — Director's Dealing 2021

Apr 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Olema Pharmaceuticals, Inc. (OLMA)
CIK: 0001750284
Period of Report: 2021-04-05

Reporting Person: Larson Yi (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-05	Stock Option (Right to Buy)	$34.80	A	21520	Acquired	2031-04-04	Common Stock (21520)	Direct
2021-04-05	Stock Option (Right to Buy)	$34.80	A	3773	Acquired	2031-04-04	Common Stock (3773)	Direct

Footnotes

F1: The shares subject to the option vest in a series of 36 successive equal monthly installments measured from April 5, 2021, subject to the Reporting Person's continuous service through each applicable vesting date.

F2: The shares subject to the option vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.